Miramar Labs, Inc.® Receives US FDA 510(k) Clearance for Reduction of Odor
miraDry nyc Treatment Device
Dec. 02, 2016

For Immediate Release:

SANTA CLARA, Calif., Nov. 07, 2016 (GLOBE NEWSWIRE) ­­ Miramar Labs, Inc., (OTCQB:MRLB), a global aesthetic company, announced today that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market for reduction of odor when patients are treated with the miraDry system. miraDry is now the first and only FDA cleared device for the non­invasive treatment of odor.

Click to Read Press Release